Market Cap (In AUD)
695.06 Million
Revenue (In AUD)
689.72 Million
Net Income (In AUD)
23.93 Million
Avg. Volume
1.31 Million
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.14-3.855
- PE
- -
- EPS
- -
- Beta Value
- 1.152
- ISIN
- AU0000148496
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ms. Melinda McGrath
- Employee Count
- -
- Website
- https://www.clinicallabs.com.au
- Ipo Date
- 2021-05-14
- Details
- Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
More Stocks
-
BRBR
-
4162
-
1448
-
EFIN
-
SFRT
-
RSRV
-
XPXP Inc.
XP
-
BPHLF